| 11078262 |
High viscosity macromolecular compositions for treating ocular conditions |
Patrick M. Hughes, Gerald W. DeVries, John T. Trogden, Scott M. Whitcup |
2021-08-03 |
|
| 9265775 |
Pharmaceutical compositions |
James N. Chang, John T. Trogden, Scott M. Whitcup |
2016-02-23 |
|
| 9089478 |
Peripherally administered viscous formulations |
Scott M. Whitcup, Michael R. Robinson, John T. Trogden |
2015-07-28 |
|
| 9039761 |
Ocular implant delivery assemblies with distal caps |
John T. Trogden, James N. Chang, Michael R. Robinson, Werhner C. Orilla |
2015-05-26 |
|
| 8992952 |
Compositions for delivery of therapeutics into the eyes and methods for making and using same |
Joseph G. Vehige, James N. Chang, Richard S. Graham, Teresa H. Kuan, Chin-Ming Chang |
2015-03-31 |
|
| 8956655 |
Biodegradable drug delivery system |
James A. Burke, Michael R. Robinson |
2015-02-17 |
$112,281,000 |
| 8846094 |
Peripherally administered viscous formulations |
Michael R. Robinson, John T. Trogden, Scott M. Whitcup |
2014-09-30 |
$56,591,000 |
| 8834884 |
Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier |
John T. Trogden |
2014-09-16 |
$104,665,000 |
| 8691802 |
Stabilized compositions comprising a therapeutically active agent and an oxidizing preservative |
Robert S. Jordan |
2014-04-08 |
$65,415,000 |
| 8642067 |
Methods and compositions for intraocular administration to treat ocular conditions |
John T. Trogden, James N. Chang, Scott M. Whitcup |
2014-02-04 |
|
| 8586556 |
Methods, compositions and drug delivery systems for intraocular delivery of siRNA molecules |
Hongwen M. Rivers, John T. Trogden |
2013-11-19 |
$53,683,000 |
| 8569272 |
Methods for treating a posterior segment of an eye |
James N. Chang, John T. Trogden, Scott M. Whitcup |
2013-10-29 |
$28,177,000 |
| 8512717 |
Compositions for delivery of therapeutics into the eyes and methods for making and using same |
Joseph G. Vehige, James N. Chang, Richard S. Graham, Teresa H. Kuan, Chin-Ming Chang |
2013-08-20 |
$16,561,000 |
| 8506962 |
Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier |
John T. Trogden |
2013-08-13 |
$12,852,000 |
| 8343949 |
Stabilized compositions comprising a therapeutically active agent, and an oxidizing preservative |
Robert S. Jordan |
2013-01-01 |
|
| 8318169 |
Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier |
John T. Trogden |
2012-11-27 |
|
| 8231892 |
Biodegradable drug delivery system |
James A. Burke, Michael R. Robinson |
2012-07-31 |
$107,535,000 |
| 8039010 |
Sustained release intraocular drug delivery systems comprising a water soluble therapeutic agent and a release modifier |
John T. Trogden |
2011-10-18 |
$27,181,000 |
| 7479134 |
Method of delivering a medication |
Orest Olejnik, Scott J. Gerondale |
2009-01-20 |
$49,818,000 |
| 7390318 |
Needleless microprotrusion elastoplast system |
Orest Olejnik, Scott J. Gerondale |
2008-06-24 |
$31,502,000 |
| 6969706 |
Preserved pharmaceutical compositions comprising cyclodextrins |
Chin-Ming Chang, James N. Chang |
2005-11-29 |
$64,499,000 |
| 6933289 |
Inhibition of irritating side effects associated with use of a topical ophthalmic medication |
James N. Chang |
2005-08-23 |
$58,065,000 |
| 6872705 |
Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions |
— |
2005-03-29 |
$20,226,000 |
| 6391832 |
Medical emulsion for lubrication and delivery of drugs |
David H. Dillard, Bruce Fieggen, Robert M. Rauker, Scott Bluni |
2002-05-21 |
|
| 6281175 |
Medical emulsion for lubrication and delivery of drugs |
David H. Dillard, Bruce Fieggen |
2001-08-28 |
|
